Challenges in Managing an Ischemic Cerebral Vascular Stroke in a Child with a Homozygote SS Sickle Cell Associated with Cerebral Palsy: A Case Study
Abstract
Introduction: Ischemic stroke is one of the most frequently observed complications of sickle cell disease. It can also be associated with cognitive impairment. These two neurological expressions of the disease can coexist in the same patient. Objective: Report a case of stroke and mental retardation in a child with homozygous SS sickle cell disease. Observation: A child aged 5 years and 8 months, homozygous sickle cell anemia, epileptic non-compliant with his antiepileptic treatment, was admitted for epileptic seizures that gradually developed over 2 months. The diagnosis of severe complicated major sickle cell syndrome was established. Discussion: The management of neurovascular, epileptic, and cognitive complications of sickle cell disease in our patient with cerebral palsy and major sickle cell disease required evaluating the risk of occurrence of severe anemia and stratification of the risk of stroke recurrence. Conclusion: Management of a major sickle cell syndrome associated with neurovascular, epileptic, and cognitive impact in a child with sickle cell disease and cerebral palsy must comply with recent recommendations.
Downloads
Metrics
References
2. Bernaudin et al., 2011; Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood, 117, 1130–40.
3. Adams et al., 1992; The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med, 326, 605–10.
4. Maitreyi et al., 2007; Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion. Pediatrics, 120(4), e1107-16.
5. Kossorotoff et al., 2012; Recommandations formalisées d’experts: prise en charge de l’AVC par le réanimateur. Particularités pédiatriques (nouveau-né exclu). Rev Neurol, 168, 527–32.
6. Sarah et al., 2011; Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis, 47(2), 125-8.
7. Ware et al., 2011; Stroke with transfusions changing to hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatr Blood Cancer, 57, 1011-7.
8. Winfred et al., 2011; The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol, 14(3), 191-7.
9. Moustapha et al., 2021; AVC de l’enfant: actualités. Revue neurologique, 177, S147.
10. Nicolaeu et al., 2023; Syndromes drépanocytaires majeurs pédiatriques et troubles cognitifs. Rev Neuropsychol, 15 (1), 53-72.
Copyright (c) 2024 Muriel Amon Tanoh, Rosette Boundjike, Nancy Tanya De-Souza, Cedric Valery Kadjo, Mody Kone, Constance Yapo-Ehounoud, Ismaila Diakite, Christian Tanoh, Evelyne Aka Diarra, Berthe Assi
This work is licensed under a Creative Commons Attribution 4.0 International License.
.jpg)
